By using ARBs alone or in combination with ACEis (Losartan + Lisinopril), we seek to elucidate the role of these medications in regulating ACE2 levels, viral replication, and overall disease outcome in experimental COVID-19. This evidence concerns the gene ACE2 and COVID-19.